Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VinoMetro: Metronomic Oral Vinorelbine in HR+/HER2- MBC
NCT03007992Phase 2Completed
- Sponsor
- Johannes Gutenberg University Mainz
- Start
- Dec 2016
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vinorelbine in breast cancer, sponsored by Johannes Gutenberg University Mainz. Started Dec 2016; status: completed.
02
Drugs
vinorelbine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03007992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03007992.